DK395687A - Leukocyt-elastase-inhibitor og dens anvendelse som laegemiddel - Google Patents

Leukocyt-elastase-inhibitor og dens anvendelse som laegemiddel

Info

Publication number
DK395687A
DK395687A DK395687A DK395687A DK395687A DK 395687 A DK395687 A DK 395687A DK 395687 A DK395687 A DK 395687A DK 395687 A DK395687 A DK 395687A DK 395687 A DK395687 A DK 395687A
Authority
DK
Denmark
Prior art keywords
leukocyt
medicine
elastase inhibitor
elastase
inhibitor
Prior art date
Application number
DK395687A
Other languages
English (en)
Other versions
DK395687D0 (da
Inventor
Klaus E Kuettner
Michael T Dimuzio
Dietrich Brocks
Dominique Tripier
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK395687D0 publication Critical patent/DK395687D0/da
Publication of DK395687A publication Critical patent/DK395687A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B24—GRINDING; POLISHING
    • B24B—MACHINES, DEVICES, OR PROCESSES FOR GRINDING OR POLISHING; DRESSING OR CONDITIONING OF ABRADING SURFACES; FEEDING OF GRINDING, POLISHING, OR LAPPING AGENTS
    • B24B53/00—Devices or means for dressing or conditioning abrasive surfaces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/84—Bones; tendons; teeth; cartilage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Mechanical Engineering (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK395687A 1986-07-30 1987-07-29 Leukocyt-elastase-inhibitor og dens anvendelse som laegemiddel DK395687A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/890,749 US4746729A (en) 1986-07-30 1986-07-30 Cartilage-derived leukocyte elastase-inhibitor

Publications (2)

Publication Number Publication Date
DK395687D0 DK395687D0 (da) 1987-07-29
DK395687A true DK395687A (da) 1988-01-31

Family

ID=25397101

Family Applications (1)

Application Number Title Priority Date Filing Date
DK395687A DK395687A (da) 1986-07-30 1987-07-29 Leukocyt-elastase-inhibitor og dens anvendelse som laegemiddel

Country Status (8)

Country Link
US (1) US4746729A (da)
EP (1) EP0257312A3 (da)
JP (1) JPS6348299A (da)
KR (1) KR880001699A (da)
AU (1) AU7624287A (da)
DK (1) DK395687A (da)
PT (1) PT85443B (da)
ZA (1) ZA875581B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4876332A (en) * 1987-10-08 1989-10-24 Regents Of The Univeristy Of Minnesota Polypeptides with type IV collagen activity
NO177716C (no) * 1989-06-09 1995-11-08 Zeneca Ltd Fremgangsmåte for fremstilling av terapeutisk aktive polypeptider, DNA-sekvens, ekspresjonsvektor og antistoff
CA2075240A1 (en) * 1991-08-05 1993-02-06 Mitsubishi Chemical Corporation Chondromodulin-ii protein
DE69435342D1 (de) 1993-07-19 2011-05-05 Angiotech Pharm Inc Anti-Angiogene Mittel und Verfahren zu deren Verwendung
US6025334A (en) * 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
US5618925A (en) * 1994-04-28 1997-04-08 Les Laboratories Aeterna Inc. Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
US6028118A (en) * 1996-08-08 2000-02-22 Les Laboratoires Aeterna Inc. Methods of using extracts of shark cartilage
US6380366B1 (en) 1994-04-28 2002-04-30 Les Laboratoires Aeterna Inc. Shark cartilage extract:process of making, methods of using and compositions thereof
RU2195946C2 (ru) 1997-03-11 2003-01-10 Ле Лабораториз Аетерна Инк. Противоопухолевые терапевтические средства, включающие комбинацию экстракта хряща и антинеопластического агента, обеспечивающие высокую эффективность действия при низких токсических побочных эффектах
US6168807B1 (en) 1998-07-23 2001-01-02 Les Laboratoires Aeterna Inc. Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof
US7034132B2 (en) * 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
DE19963006A1 (de) * 1999-12-24 2001-06-28 Bosch Gmbh Robert Verfahren und Vorrichtung zur Erfassung und Auswertung von Objekten im Umgebungsbereich eines Fahrzeuges
WO2002099116A2 (en) * 2001-06-04 2002-12-12 Curagen Corporation Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003018620A2 (en) * 2001-08-27 2003-03-06 Les Laboratoires Aeterna Inc. Serine protease inhibitor and processes for the preparation thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4042457A (en) * 1975-11-10 1977-08-16 Rush-Presbyterian-St. Luke's Medical Center Preparation of tissue invasion inhibitor and method of treatment utilizing the inhibitor
USRE30239E (en) * 1975-11-10 1980-03-25 Cell proliferation and tissue invasion inhibitor
US4356261A (en) * 1980-04-22 1982-10-26 Rush-Presbyterian-St. Luke's Medical Center Anti-invasion factor containing cultures
FR2487198A1 (fr) * 1980-07-28 1982-01-29 Berri Balzac Sa Nouvelle substance immuno-suppressive, son procede d'isolement et son application en therapeutique
DE3109629A1 (de) * 1981-03-13 1982-09-23 Behringwerke Ag, 3550 Marburg "neues protein (pp(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)), verfahren zu seiner anreicherung und gewinnung sowie seine verwendung"
JPS6028999A (ja) * 1983-06-30 1985-02-14 Maruho Kk 細胞増殖促進作用を有するたんぱく質、その組成物と製造方法

Also Published As

Publication number Publication date
ZA875581B (en) 1990-06-27
JPS6348299A (ja) 1988-02-29
US4746729A (en) 1988-05-24
PT85443B (en) 1989-12-07
PT85443A (en) 1987-08-01
KR880001699A (ko) 1988-04-26
EP0257312A2 (en) 1988-03-02
EP0257312A3 (en) 1989-10-25
AU7624287A (en) 1988-02-11
DK395687D0 (da) 1987-07-29

Similar Documents

Publication Publication Date Title
NO874632D0 (no) Cyclodextrinclathrater av carbacyclinderivater og deres anvendelse som legemiddel.
DK414189D0 (da) Aminosyreforbindelse og dens anvendelse
BR8906977A (pt) Andaime
KR880701672A (ko) 유체 토출 기구
DK395687D0 (da) Leukocyt-elastase-inhibitor og dens anvendelse som laegemiddel
DE68928024D1 (de) Schalter
DK14988A (da) Malariavaccine og dens anvendelse
DK75991D0 (da) Koedkroplasthaandtering
DE58903320D1 (de) Alpha-fluorcarbonsaeurecyclohexylester.
DK116087D0 (da) 2-oeheterocyclylmethylsulfinylaathienoimidazol-forbindelser og deres anvendelse som antiulcusmidler
DK163088D0 (da) Dopamin-beta-hydroxylase inhibitor
DK440887D0 (da) Dopamin-beta-hydroxylase-inhibitorer
FI875603A (fi) Renin-inhibitorer iv.
DK161989A (da) Acrylsyrederivater
DK380987D0 (da) Korrosionsinhibitor, dens fremstilling og anvendelse
DK343688A (da) Benzodipyranforbindelse og dens farmaceutiske anvendelse
DK238486A (da) 2,4-dichlor-5-nitro-thiazol, dens fremstilling og anvendelse som mikrobiocid
DK590487D0 (da) Fotoinitiator
DK573487D0 (da) Cyklodextrinclathrater af carbacyklinderivater og anvendelse deraf som laegemiddel
SE8802845D0 (sv) Blodror/vetskeror
DK485388D0 (da) Gamache
BR6601545U (pt) Valvula anti-refluxo
KR880013926U (ko) 병렬 입출력 상향 카운터
CA57576S (fr) Vitrine
IT8741702A0 (it) Ciclo a doppio azionamento contemporaneo e/o alternativo per usi sportivi e curativi.

Legal Events

Date Code Title Description
ATS Application withdrawn